Page last updated: 2024-10-16

adenine and Hormone-Dependent Neoplasms

adenine has been researched along with Hormone-Dependent Neoplasms in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Amonafide was given at a dose of 225 mg/m2 intravenously daily for 5 days."2.67Phase II trial of amonafide for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group study. ( Ahmann, F; Blumenstein, B; Craig, JB; Crawford, ED; Eisenberger, M; Marshall, ME; Thompson, IM, 1994)
"The androgen dependent prostate cancer cell line, LNCaP, expresses the ErbB-1, ErbB-2 and ErbB-3 receptor tyrosine kinases."1.38Neuregulin promotes incomplete autophagy of prostate cancer cells that is independent of mTOR pathway inhibition. ( Ehrlich, M; Pinkas-Kramarski, R; Schmukler, E; Shai, B, 2012)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmukler, E1
Shai, B1
Ehrlich, M1
Pinkas-Kramarski, R1
Amaral, C1
Varela, C1
Azevedo, M1
da Silva, ET1
Roleira, FM1
Chen, S1
Correia-da-Silva, G1
Teixeira, N1
Marshall, ME1
Blumenstein, B1
Crawford, ED1
Thompson, IM1
Craig, JB1
Eisenberger, M1
Ahmann, F1

Trials

1 trial available for adenine and Hormone-Dependent Neoplasms

ArticleYear
Phase II trial of amonafide for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group study.
    American journal of clinical oncology, 1994, Volume: 17, Issue:6

    Topics: Adenine; Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Drug Administration Schedul

1994

Other Studies

2 other studies available for adenine and Hormone-Dependent Neoplasms

ArticleYear
Neuregulin promotes incomplete autophagy of prostate cancer cells that is independent of mTOR pathway inhibition.
    PloS one, 2012, Volume: 7, Issue:5

    Topics: Acetylcysteine; Adenine; Anthracenes; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Death

2012
Effects of steroidal aromatase inhibitors on sensitive and resistant breast cancer cells: aromatase inhibition and autophagy.
    The Journal of steroid biochemistry and molecular biology, 2013, Volume: 135

    Topics: Adenine; Androstanes; Aromatase Inhibitors; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Surv

2013